MFS Blended Research Value Equity R2 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MFS Blended Research Value Equity Fund Class R2 BRUKX
- NAV / 1-Day Return 18.88 / +0.48 %
- Total Assets 347.6M
-
Adj. Expense Ratio
0.890%
- Expense Ratio 0.920%
- Distribution Fee Level Low
- Share Class Type Retirement, Medium
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.85%
- Turnover 50%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:06 AM GMT+0
Morningstar’s Analysis BRUKX
Will BRUKX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Apple Inc | 5.61 | 20M | Technology |
Amazon.com Inc | 5.59 | 20M | Consumer Cyclical |
Microsoft Corp | 4.02 | 14M | Technology |
Johnson & Johnson | 3.06 | 11M | Healthcare |
Salesforce Inc | 1.81 | 6M | Technology |
Citigroup Inc | 1.79 | 6M | Financial Services |
Pfizer Inc | 1.79 | 6M | Healthcare |
Gilead Sciences Inc | 1.72 | 6M | Healthcare |
Northern Trust Corp | 1.56 | 6M | Financial Services |
Valero Energy Corp | 1.53 | 5M | Energy |